Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a picture tool help kids with cancer say how they feel?

NCT ID NCT04433650

Symptom relief Sponsor: Göteborg University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers are testing a digital picture-based tool that lets children with cancer report symptoms and distress during high-dose methotrexate treatment. The study includes children aged 5 to 17, their guardians, and healthcare professionals. Children use the tool to rate distress on a 0 to 10 scale, and researchers measure stress and pain biomarkers in blood samples. The goal is to see if this person-centred approach improves communication and symptom management.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A digital picture-based communication tool that lets children report symptoms and distress
What this could lead to
If the tool works, children with cancer could communicate distress more easily during treatment, and the same picture-based approach could be used in hospitals across different countries.
What could go wrong
This is a small study of 29 children in one treatment setting, so the results may not apply broadly. The tool may not capture distress better than standard care, and some children may find it hard to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

29 people

The number who actually took part.

Started

Mar 2021

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children with cancer, 5-17 years * The children´s legal guardians * Healthcare professionals who take care of these children * The child needs to have a cognitive level of approximately five years (i.e., be able to understand a numeric rating scale (NRS)). Exclusion Criteria: \- Children 0-4 years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Childhood cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm Communication neoplasm Signs and Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Childhood cancer Communication Symptoms and signs

Contacts and locations

Locations

  • University of Gothenburg

    Gothenburg, 40530, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.